Galenica has increased its ownership stake in Puravita to 80%, aiming to strengthen its digital presence in the Swiss pharmacy market.

Information on the Target

Galenica has significantly expanded its investment in Puravita AG, increasing its stake from 34% to 80%, thereby becoming the majority shareholder. This strategic move aims to enhance Galenica's digital offerings in the retail and pharmacy sectors, particularly in the online space. Puravita, founded in 2016 and a partner of Galenica since 2020, offers an extensive online selection with over 45,000 products within the Swiss pharmacy, drugstore, and health market.

The company, based in Speicher (AR), generates an annual net revenue of approximately CHF 22 million and employs 48 staff members. Under the leadership of its founder, Michael Sonderegger, Puravita has demonstrated a strong commitment to digital customer engagement and has positioned itself as a prominent player in the growing online health market.

Industry Overview in Switzerland

The Swiss retail pharmaceutical market is experiencing a notable transformation, driven by the increasing integration of online services and traditional brick-and-mortar establishments. The growth of e-commerce has become a cruc